Featured Research

from universities, journals, and other organizations

VUMC Begins Using Leukoreduced Blood For All Patients

Date:
October 1, 1998
Source:
Vanderbilt University Medical Center
Summary:
Vanderbilt University Medical Center has become one of the first academic medical centers to use leukoreduced blood products, which can carry disease and suppress the human body's immune system, for all patients in the medical center.

Vanderbilt University Medical Center has become one of the first academic medical centers in the nation — and the only hospital in the region — to expand the use of leukoreduced blood products to all patients.

Related Articles


These products are filtered to remove plasma and white blood cells, or leukocytes, which can carry disease, cause transfusion reactions and suppress the human body's immune system.

Previously, leukoreduced blood has been used only on those patients who require chronic transfusions or are very immune-suppressed, such as bone marrow transplant patients.

"Leukoreduced blood is going to become the standard for the entire nation," said Dr. Anne T. Thomas, assistant professor of Pathology and Medicine and director of Vanderbilt's Blood Bank. "In addition to being safer for patients it has the potential for saving money by reducing postoperative infections."

In September, VUMC became one of only a handful of institutions to expand the use of leukoreduced blood to all of its patients, instead of limiting their use to a few of the sickest patients.

One of the main concerns during transfusions for bone marrow transplant patients is the production of HLA antibodies, which can cause several problems following transfusion. They can cause fever, contribute to transplanted tissue rejection and render a patient unresponsive to vital platelet transfusions used to control or prevent bleeding.

In normal cases, white blood cells fight infection in the body. During blood transfusions or tissue transplants, the donor's white blood cells can induce the patient to form these HLA antibodies. The leukocytes can also produce reactions to blood products via chemicals called cytokines that they release into the product during storage.

"White blood cells can also carry diseases such as cytomegalovirus (CMV), which most all of us carry and usually causes nothing more then a cold-type illness. In patients whose immune system is disturbed in some way, the virus can be fatal," said Thomas.

The risk of CMV has receded as hospitals began using leukoreduced blood for patients with compromised immune systems. It is hoped that by using leukoreduced blood for a hospital's entire patient population, the number of postoperative infections and the amount of antibiotics used for each patient can be reduced.

"There have been studies that show leukoreduced blood helps reduce infections for patients undergoing elective surgeries. These were all very well controlled conditions. Further study of these blood products is needed to determine if they will help other patients in the hospital," said Thomas.

Trauma patients are one population that Thomas hopes to study once the leukoreduced blood is in use throughout the hospital. One of the major complications with these patients is that their injuries often lead to infection. These infections can be life threatening and often linger once the initial surgery is completed.

"Studying effects of this blood in the emergency room is something that we think is important even if we will not be able to have a double blind study," said Thomas.

The donation process itself will remain unchanged for those donating blood. After the blood is collected into one bag, it is then filtered into three different bags.

Once the process is complete there are three separate blood products in each bag: leukoreduced red blood cells, leukoreduced platelets, and leukoreduced plasma.

"If you ask a blood banker — or really anyone who knows about blood products — which they would rather get if they need a transfusion, they will tell you they want leukoreduced blood," said Thomas.

"This is not only better for our patients but in the long run could save us some money by reducing postoperative infections and the number of intravenous antibacterial drugs that we have to give our patients for those infections."

All of VUMC's leukoreduced blood will be provided by the American Red Cross and filtered with a system from the Pall, Corporation.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "VUMC Begins Using Leukoreduced Blood For All Patients." ScienceDaily. ScienceDaily, 1 October 1998. <www.sciencedaily.com/releases/1998/09/980930115929.htm>.
Vanderbilt University Medical Center. (1998, October 1). VUMC Begins Using Leukoreduced Blood For All Patients. ScienceDaily. Retrieved January 31, 2015 from www.sciencedaily.com/releases/1998/09/980930115929.htm
Vanderbilt University Medical Center. "VUMC Begins Using Leukoreduced Blood For All Patients." ScienceDaily. www.sciencedaily.com/releases/1998/09/980930115929.htm (accessed January 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, January 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC: Get Vaccinated for Measles

CDC: Get Vaccinated for Measles

Reuters - US Online Video (Jan. 30, 2015) The CDC is urging people to get vaccinated for measles amid an outbreak that began at Disneyland and has now infected more than 90 people. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Obama To Outline New Plan For Personalized Medicine

Obama To Outline New Plan For Personalized Medicine

Newsy (Jan. 30, 2015) President Obama is expected to speak with drugmakers Friday about his Precision Medicine Initiative first introduced last week. Video provided by Newsy
Powered by NewsLook.com
NFL Concussions Down; Still on Parents' Minds

NFL Concussions Down; Still on Parents' Minds

AP (Jan. 30, 2015) The NFL announced this week that the number of game concussions dropped by a quarter over last season. Still, the dangers of the sport still weigh on players, and parents&apos; minds. (Jan. 30) Video provided by AP
Powered by NewsLook.com
U.S. Wants to Analyze DNA from 1 Million People

U.S. Wants to Analyze DNA from 1 Million People

Reuters - US Online Video (Jan. 30, 2015) The U.S. has proposed analyzing genetic information from more than 1 million American volunteers to learn how genetic variants affect health and disease. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins